Integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer

Journal of Zhejiang University: Science

Volumn 6 B, Issue 4, 2005, Pages 227-231

  Yu, Jie Kai ^a,b   Zheng, Shu ^a   Tang, Yong ^c   Li, Li ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Ovarian cancer; Proteomics; SELDI TOF; SVM

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; DESORPTION; DIAGNOSIS; INFORMATION TECHNOLOGY; IONIZATION; MASS SPECTROMETRY;

BIOINFORMATICS; HEALTHY PEOPLE; OVARIAN CANCER; PROTEOMICS; SUPPORT VECTOR MACHINE;

DISEASE CONTROL;

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGY; BLOOD; FEMALE; HUMAN; LASER; MASS SPECTROMETRY; MIDDLE AGED; OVARY TUMOR; PEPTIDE MAPPING; PREDICTION AND FORECASTING; PROTEOMICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; LASERS; MASS SPECTROMETRY; MIDDLE AGED; OVARIAN NEOPLASMS; PEPTIDE MAPPING; PREDICTIVE VALUE OF TESTS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 17244371391     PISSN: 10093095     EISSN: None     Source Type: Journal    
DOI: 10.1631/jzus.2005.B0227     Document Type: Article

References (16)

1. Adam, B., Qu, Y., Davis, J.W., Ward, M.D., Clements, M.A., Cazares, L.H., Semmens, O.J., Schellhammer, P.P., Yasui, Y., Ziding, F., Wright, G., 2002. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyper-plasia and healthy men. Cancer Res, 62(13): 3609-3614.
2. Bast, R.C.Jr., Xu, F.J., Yu, Y.H., Barnhill, S., Zhang, Z., Mills, G.B., 1998. CA125: the past and the future. Int J Biol Markers, 13(4): 179-187.
3. Chen, Y.D., Zheng, S., Yu, J.K., Hu, X., 2004. Application of serum protein pattern model in diagnosis of colorectal cancer. Zhonghua Zhong Liu Za Zhi, 26(7): 417-420 (in Chinese).
4. Hu, Y., Zhang, S.Z., Yu, J.K., Liu, J., Zheng, S., 2004. Detection and evaluation of serum proteomic patterns by SELDI-TOF-MS in breast cancer. Zhong Hua Jian Yan Zha Zhi, 27(10): 646-648 (in Chinese).
5. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y.Y., Chan, D.W., 2002. Proteomics and bioinformatics approached for identification of serum biomarkers to detect breast cancer. Clin Chem, 48(8): 1296-1304.
6. Mok, S.C., Chao, J., Skates, S., Wong, K., Yiu, O.K., Muto, M.G., Berkowitz, R.S., Cramer, D.W., 2001. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst, 93(19): 1458-1464.
7. Petricoin, E.F., Liotta, L.A., 2004. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol, 15(1): 24-30.
8. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., Liotta, L.A., 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359(9306): 572-577.
9. Poon, T.C.W., Yip, T.T., Chan, A.T.C., Yip, C., Yip, V., Mok, T.S.K., Lee, C.C.Y., Leung, T.W.T., Ho, S.K.W., Johnson, P.J., 2002. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem, 49(5): 752-760.
10. Rai, A.J., Zhang, Z., Rosenzweig, J., Shih, Ie.M., Pham, T., Fung, E.T., Sokoll, L.J., Chan, D.D., 2002. Proteomic approaches to tumor marker discovery. Arch Pathol Lab Med, 126(12): 1518-1526.
11. Srinivas, P.R., Verma, M., Zhao, Y., Srivastava, S., Clark, R.A., Tockman, M.S., 2002. Proteomics for cancer bio-marker discovery. Clin. Chem, 48(8): 1160-1169.
12. Vapnik, V., 1995. The Nature of Statistical Learning Theory. Springer Verlag, New York.
13. Wiesner, A., 2004, Detection of tumor markers with ProteinChip technology. Curr Pharm Biotechnol, 51: 45-67.
14. Ye, B., Cramer, D.W., Skates, S.J., Gygi, S.P., Pratomo, V., Fu, L., Horick, N.K., Licklider, L.J., Schorge, J.O., Berkowitz, R.S., Mok, S.C., 2003. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res, 9(8): 2904-2915.
15. Yu, J.K., Chen, Y.D., Zheng, S., 2004. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics, World J Gastroenterol, 10(21): 3127-3131.
16. Zhang, Z., Bast, R.C.Jr, Yu, Y., Li J., Sokoll, L.J., Rai, A.J., Rosenzweig, J.M., Cameron, B., Wang, Y.Y., Meng, X.Y., Berchuck, A., Van Haaften-Day, C., Hacker, N.F., de Bruijn, H.W., van der Zee, A.G., Jacobs, I.J., Fung, E.T., Chan, D.W., 2004. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res, 64(16): 5882-5890.